Rapid differentiation of MOGAD and MS after a single optic neuritis
Following a single ON-episode, MOGAD exhibits more pronounced global pRNFL atrophy and lower visual acuity after ON compared to MS. The introduced OCT-based composite score enabled differentiation between the two entities across both cohorts.
Authors
- Ana Beatriz Ayroza Galvão Ribeiro Gomes (ORCID: https://orcid.org/0000-0003-1657-6891)
- Christiane Schneider‐Gold (ORCID: https://orcid.org/0000-0002-9232-201X)
- Laila Kulsvehagen (ORCID: https://orcid.org/0000-0001-5236-8323)
- Carolin Schwake (ORCID: https://orcid.org/0000-0003-3669-7244)
- N. Stolowy
- Tania Kümpfel (ORCID: https://orcid.org/0000-0001-7509-5268)
- Philipp Albrecht (ORCID: https://orcid.org/0000-0001-7987-658X)
- Barbara Kornek (ORCID: https://orcid.org/0000-0002-1851-6967)
- Ankelien Duchow (ORCID: https://orcid.org/0000-0003-0854-7521)
- Gabriel Bsteh (ORCID: https://orcid.org/0000-0002-0825-0851)
- Anke Salmen (ORCID: https://orcid.org/0000-0002-4751-299X)
- Thivya Pakeerathan
- Kerstin Hellwig (ORCID: https://orcid.org/0000-0003-4467-9011)
- Orhan Aktaş (ORCID: https://orcid.org/0000-0002-2020-9210)
- Marius Ringelstein (ORCID: https://orcid.org/0000-0001-8619-1327)
- Joachim Havla (ORCID: https://orcid.org/0000-0002-4386-1340)
- Jonathan A. Gernert (ORCID: https://orcid.org/0000-0002-6655-5557)
- Friedemann Paul (ORCID: https://orcid.org/0000-0002-6378-0070)
- Ralf Gold (ORCID: https://orcid.org/0000-0002-7223-3052)
- Frederike Cosima Oertel (ORCID: https://orcid.org/0000-0003-4906-5983)
- Nuria Cerdá-Fuertes (ORCID: https://orcid.org/0000-0001-8753-5267)
- Athina Papadopoulou (ORCID: https://orcid.org/0000-0002-0367-1008)
- Ilya Ayzenberg
- M. Weise
- A-K Pröbstel
- Jan-Patrick Stellmann
Institutions
- Centre National de la Recherche Scientifique (FR)
- University of Basel (CH)
- University Hospitals of the Ruhr-University of Bochum (DE)
- University Hospital of Basel (CH)
- Humboldt-Universität zu Berlin (DE)
- Kliniken Maria Hilf (DE)
- Department of Biomedicine Basel (CH)
- St. Josef-Hospital (DE)
- Centre de Résonance Magnétique Biologique et Médicale (FR)
- Hôpital de la Timone (FR)
- Heinrich Heine University Düsseldorf (DE)
- Medical University of Vienna (AT)
- Ludwig-Maximilians-Universität München (DE)
- Ruhr University Bochum (DE)
Publication Details
- Journal
- Journal of Neurology
- Published
- 2024-09-09
- DOI
- https://doi.org/10.1007/s00415-024-12666-w
- Citations
- 9
- Primary Topic
- Multiple Sclerosis Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 3.82
Funders
- National Science Foundation
- Bristol-Myers Squibb
- Eli Lilly and Company
- Bayer
- Sanofi
- Biogen
- Teva Pharmaceutical Industries
- Alexion Pharmaceuticals
- Celgene
- Guthy-Jackson Charitable Foundation
- CSL Behring
- European Committee for Treatment and Research in Multiple Sclerosis
- University of Bern
- Amicus Therapeutics
- Universitätsspital Basel
- Argenx
- Horizon Therapeutics
- Multiple Sclerosis Society
- Deutsche Forschungsgemeinschaft
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung
- Bundesministerium für Bildung und Forschung
- Deutsche Gesellschaft für Neurologie
- Schweizerische Multiple Sklerose Gesellschaft
- H. Lundbeck A/S
- Ipsen
- Allergan
- Novartis Pharma
- Chugai Pharmaceutical
- Sanofi Genzyme
- Bayer Vital